Latest filing published 06 May 2025 for Fusion Antibodies plc, €7,276.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +126.9%Entry £0.06 · Close at T+365 £0.14
- +245.2%Entry £0.04 · Close at T+365 £0.15
- +339.4%Entry £0.03 · Close at T+365 £0.15
- +14.7%Entry £0.05 · Close at T+365 £0.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Adrian Kinkaid: trading record in brief
Adrian Kinkaid appears in our data through filings on Fusion Antibodies plc shares, published by RNS (LSE). Over a trading history stretching from 20 September 2022 to 6 May 2025, the count stands at 5 filings.
Purchases make up the whole of the open-market record (5 purchases, €24k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2025: 1 purchase and no sales on the market.
In size, the median ticket on the buying side is €4,511. Clusters matter here: 1 out of 5 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. After 4 purchases with a full 90-day history, the hit rate stands at 75% and the median 90-day move at +75.5%. Past outcomes like these are no guarantee of what comes next.
The record was last updated on 6 May 2025 with an open-market purchase (€7,276) in Fusion Antibodies plc. The median gap between trade and publication is zero days: most filings appear on the same day. The regulation allows three business days to notify a trade (UK MAR). These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to Adrian Kinkaid
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100,000 shares@ £0.061833.4% of flowXLON, London Stock ExchangeISIN GB00BDQZGK16RNS:5642517Canonical exit: 4 Aug 2025 (T+90)
- 83,728 shares@ £0.041919.2% of flowXLON, London Stock ExchangeISIN GB00BDQZGK16RNS:5392116Canonical exit: 14 Jan 2025 (T+90)
- 120,000 shares@ £0.031720.7% of flowXLON, London Stock ExchangeISIN GB00BDQZGK16RNS:5337535Canonical exit: 4 Dec 2024 (T+90)
- 101,847 shares@ £0.04926.7% of flowXLON, London Stock ExchangeISIN GB00BDQZGK16RNS:4991240-1Canonical exit: 3 Mar 2024 (T+90)
4 of 4 declarations